Composite smart mesoporous silica nanoparticles as promising therapeutic and diagnostic candidates: Recent trends and applications

Abstract Theranostics is an emerging field which involves application of a single formulation for both diagnosis as well as therapeutics. The present manuscript describes various applications of hybrid mesoporous silica nanoparticles in therapeutics, diagnostics and in theranostics. In spite of advancement in medicine, early diagnosis and complete treatment of various diseases like cancers, HIV and diabetes still remains a daunting task. The answer to the treatment of these deadly diseases lies in the vast research done on smart functionally modified mesoporous silica nanoparticles. The promising results given by MSNs in various in vitro and in vivo studies, accounts for the overwhelming attention they are receiving in the field of drug delivery and diagnostics. Their effect on immune system has also been outlined. Applications are also being reported in the field of gene delivery. Due to wide applications, these multifunctional Nano carriers are befitted for the job of drug delivery and cell tracking. Their role as contrast agents in the field of diagnostics is also described. The manuscript focusses on construction strategies, applications, challenges and opportunities associated with this emerging Nano drug delivery technology. Though Mesoporous silica nanoparticles have already entered pre-clinical development stage, their testing in clinical trials on a large scale needs to be accomplished to establish their efficacy and safety in humans. The ultimate goal of these astute composite mesoporous carriers is to utilize diagnostic information for controlling their therapeutic function. Smart multifunctional MSNs have a great potential ahead and can be the answer to cure of various deadly diseases.

[1]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[2]  R. Zhuo,et al.  A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. , 2015, Journal of materials chemistry. B.

[3]  Y. Barenholz,et al.  Annals of the New York Academy of Sciences Nanomedicines: Addressing the Scientific and Regulatory Gap , 2022 .

[4]  J. S. Beck,et al.  Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism , 1992, Nature.

[5]  Jia Guo,et al.  Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release , 2011 .

[6]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[7]  T. Meade,et al.  Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging , 2009, MRS bulletin.

[8]  F. Kleitz,et al.  Cubic Ia3d large mesoporous silica: synthesis and replication to platinum nanowires, carbon nanorods and carbon nanotubes. , 2003, Chemical communications.

[9]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.

[10]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[11]  Julia Cordek,et al.  Direct Immobilization of Glutamate Dehydrogenase on Optical Fiber Probes for Ultrasensitive Glutamate Detection , 1999 .

[12]  Lehui Lu,et al.  Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. , 2012, Accounts of chemical research.

[13]  Andrew A. Burns,et al.  Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. , 2006, Chemical Society reviews.

[14]  H. Kang,et al.  Heat shock responsive drug delivery system based on mesoporous silica nanoparticles coated with temperature sensitive gatekeeper , 2017 .

[15]  Z. Wang,et al.  Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma. , 2017, ACS nano.

[16]  S. Tjin,et al.  The application of mesoporous silica nanoparticle family in cancer theranostics , 2016 .

[17]  Scott C. Brown,et al.  Nanoparticles for bioimaging. , 2006, Advances in colloid and interface science.

[18]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles in medicine--recent advances. , 2013, Advanced drug delivery reviews.

[19]  Xiaolian Sun,et al.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. , 2017, Chemical Society reviews.

[20]  Éva Tóth,et al.  The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging , 2013 .

[21]  Seong Huh,et al.  Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method , 2003 .

[22]  Xinwen Guo,et al.  Facile synthesis of mesoporous silica nanoparticles with controlled morphologies using water–acetone media , 2010 .

[23]  Qinfu Zhao,et al.  Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. , 2015, Acta biomaterialia.

[24]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[25]  L. Gao,et al.  Synthesis, characterization and optical properties of CdS nanoparticles confined in SBA-15 , 2005 .

[26]  T. Asefa,et al.  Biocompatibility of mesoporous silica nanoparticles. , 2012, Chemical research in toxicology.

[27]  R A Perez,et al.  Therapeutic bioactive microcarriers: co-delivery of growth factors and stem cells for bone tissue engineering. , 2014, Acta biomaterialia.

[28]  Juan L. Vivero-Escoto,et al.  Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments , 2016 .

[29]  Jos L. Campbell,et al.  Theranostic Mesoporous Silica Nanoparticles Biodegrade after Pro-Survival Drug Delivery and Ultrasound/Magnetic Resonance Imaging of Stem Cells , 2015, Theranostics.

[30]  M. B. Cardoso,et al.  Viral Inhibition Mechanism Mediated by Surface-Modified Silica Nanoparticles. , 2016, ACS applied materials & interfaces.

[31]  Monty Liong,et al.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells , 2007, Nanobiotechnology : the journal at the intersection of nanotechnology, molecular biology, and biomedical sciences.

[32]  Jun Zhou,et al.  A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells. , 2016, Cancer research.

[33]  Jianlin Shi,et al.  In Vivo Bio‐Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles , 2013, Advanced materials.

[34]  Indrajit Roy,et al.  Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. , 2008, ACS nano.

[35]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[36]  Feng Chen,et al.  Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. , 2013, Nanomedicine.

[37]  Tingting Wang,et al.  Multifunctional hollow mesoporous silica nanocages for cancer cell detection and the combined chemotherapy and photodynamic therapy. , 2011, ACS applied materials & interfaces.

[38]  Younan Xia,et al.  Inorganic nanoparticle-based contrast agents for molecular imaging. , 2010, Trends in molecular medicine.

[39]  Changjun Hou,et al.  Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo , 2015, Nanotechnology.

[40]  Xiaojun Cai,et al.  Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release. , 2012, ACS applied materials & interfaces.

[41]  S. Rankin,et al.  Dual latex/surfactant templating of hollow spherical silica particles with ordered mesoporous shells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[42]  Chin-Tu Chen,et al.  Near‐Infrared Mesoporous Silica Nanoparticles for Optical Imaging: Characterization and In Vivo Biodistribution , 2009 .

[43]  Leone Spiccia,et al.  Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. , 2014, Small.

[44]  Avelino Corma,et al.  From Microporous to Mesoporous Molecular Sieve Materials and Their Use in Catalysis. , 1997, Chemical reviews.

[45]  A. Corma,et al.  AlITQ-6 and TiITQ-6: Synthesis, Characterization, and Catalytic Activity We thank the Spanish CICYT for financial support (project MAT97-1016-C02-01 and project MAT97-1207-C03-01). U.D. and M.E.D. thank the M.E.C. and M.E.A., respectively, for funding their doctoral fellowships. , 2000, Angewandte Chemie.

[46]  Chung-Yuan Mou,et al.  Well-Ordered Mesoporous Silica Nanoparticles as Cell Markers , 2005 .

[47]  G. Somorjai,et al.  Hydrothermal growth of mesoporous SBA-15 silica in the presence of PVP-stabilized Pt nanoparticles: synthesis, characterization, and catalytic properties. , 2006, Journal of the American Chemical Society.

[48]  Xue Shen,et al.  Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites. , 2017, Biomaterials science.

[49]  F. Marmottini,et al.  Use of SBA-15 for furosemide oral delivery enhancement. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[50]  Sang Bong Lee,et al.  Mesoporous silica nanoparticle pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body. , 2013, Angewandte Chemie.

[51]  K. Cheng,et al.  Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments. , 2012, ACS applied materials & interfaces.

[52]  Mykhailo V Bondar,et al.  Folate receptor-targeted aggregation-enhanced near-IR emitting silica nanoprobe for one-photon in vivo and two-photon ex vivo fluorescence bioimaging. , 2011, Bioconjugate chemistry.

[53]  R. Srivastava,et al.  Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics. , 2016, Nanoscale.

[54]  G. Kaluđerović,et al.  Silicon-based nanotheranostics. , 2017, Nanoscale.

[55]  H. Kim,et al.  Silica-based mesoporous nanoparticles for controlled drug delivery , 2013, Journal of tissue engineering.

[56]  Jiang Chang,et al.  Degradation of hollow mesoporous silica nanoparticles in human umbilical vein endothelial cells. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[57]  T. Bein,et al.  Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. , 2009, Angewandte Chemie.

[58]  Victor S-Y Lin,et al.  Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system. , 2011, Chemical communications.

[59]  Weihong Tan,et al.  Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. , 2003, Journal of the American Chemical Society.

[60]  J. B. Higgins,et al.  A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .

[61]  Lisa R. Hilliard,et al.  A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[63]  B. Polyak,et al.  Magnetic targeting for site-specific drug delivery: applications and clinical potential , 2009, Expert opinion on drug delivery.

[64]  G. Øye,et al.  Synthesis, characterization and potential applications of new materials in the mesoporous range. , 2001, Advances in colloid and interface science.

[65]  V. Alfredsson,et al.  Structure of MCM-48 Revealed by Transmission Electron Microscopy , 1996 .

[66]  Xing Li,et al.  A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. , 2011, Contrast media & molecular imaging.

[67]  Zhouhua Wang,et al.  Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery , 2015, Journal of Nanobiotechnology.

[68]  Chunhua Yan,et al.  Optical sensors based on functionalized mesoporous silica SBA-15 for the detection of multianalytes (H+ and Cu2+) in water , 2007 .

[69]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[70]  Huibi Xu,et al.  Controllable synthesis of hollow mesoporous silica nanoparticles templated by kinetic self-assembly using a gemini surfactant , 2013 .

[71]  R. Clarke,et al.  ATP binding cassette transporters and drug resistance in breast cancer. , 2003, Endocrine-related cancer.

[72]  X. Yang,et al.  Alizarin Complexone Functionalized Mesoporous Silica Nanoparticles: A Smart System Integrating Glucose-Responsive Double-Drugs Release and Real-Time Monitoring Capabilities. , 2016, ACS applied materials & interfaces.

[73]  Cecilia Sahlgren,et al.  Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. , 2011, Current drug targets.

[74]  Changbong Hyeon,et al.  Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. , 2012, Small.

[75]  J. S. Beck,et al.  Development of a formation mechanism for M41S materials , 1994 .

[76]  C. Mehnert,et al.  Synthese und Anwendungen von mit supramolekularen Templaten hergestellten mesoporösen Materialien , 1999 .

[77]  M. E. EL- NABARAWI,et al.  Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization , 2016, Drug delivery.

[78]  M. Jaroniec,et al.  Characterization of the Porous Structure of SBA-15 , 2000 .

[79]  E. Tasciotti,et al.  Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity , 2017, Journal of Neuroimmune Pharmacology.

[80]  P. Choyke,et al.  New strategies for fluorescent probe design in medical diagnostic imaging. , 2010, Chemical reviews.

[81]  Angelos A. Lappas,et al.  Evaluation of various types of Al-MCM-41 materials as catalysts in biomass pyrolysis for the production of bio-fuels and chemicals , 2006 .

[82]  Y. Liu,et al.  Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors. , 2015, Journal of biomedical nanotechnology.

[83]  Mithat Gönen,et al.  Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.

[84]  Zheng Han,et al.  Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer. , 2016, ACS biomaterials science & engineering.

[85]  P. Chou,et al.  A Versatile Theranostic Delivery Platform Integrating Magnetic Resonance Imaging/Computed Tomography, pH/cis-Diol Controlled Release, and Targeted Therapy. , 2016, ACS nano.

[86]  Juan L. Vivero-Escoto,et al.  Silica-based nanoprobes for biomedical imaging and theranostic applications. , 2012, Chemical Society reviews.

[87]  D. Zhao,et al.  Synthesis of mesoporous manganosilicates Mn-MCM-41, Mn-MCM-48 and Mn-MCM-L at a low surfactant/Si ratio , 1995 .

[88]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[89]  Xian‐Zheng Zhang,et al.  MMP-responsive theranostic nanoplatform based on mesoporous silica nanoparticles for tumor imaging and targeted drug delivery. , 2016, Journal of materials chemistry. B.

[90]  W. Tremel,et al.  Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐Alpha , 2017, Advanced healthcare materials.

[91]  Yuan Luo,et al.  Rapid-releasing of HI-6 via brain-targeted mesoporous silica nanoparticles for nerve agent detoxification. , 2016, Nanoscale.

[92]  Yu Chen,et al.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.

[93]  Lin Mei,et al.  pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy. , 2017, ACS applied materials & interfaces.

[94]  Junqing Hu,et al.  The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy. , 2014, Biomaterials.

[95]  J. Riess,et al.  Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. , 2003, Angewandte Chemie.

[96]  G. Buntkowsky,et al.  Hydrogen bonding of water confined in mesoporous silica MCM-41 and SBA-15 studied by 1H solid-state NMR. , 2004, Chemistry.

[97]  Li Yuan,et al.  Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery , 2011 .

[98]  Shiyong Liu,et al.  Fluorescent pH-sensing organic/inorganic hybrid mesoporous silica nanoparticles with tunable redox-responsive release capability. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[99]  A. Windhorst,et al.  Pretargeted PET Imaging of trans-Cyclooctene-Modified Porous Silicon Nanoparticles , 2017, ACS omega.

[100]  Antonino Giovia,et al.  Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles , 2012, International journal of nanomedicine.

[101]  Jiang He,et al.  Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy. , 2016, Journal of biomedical nanotechnology.

[102]  Hyesung Jeon,et al.  Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. , 2011, ACS nano.

[103]  Fredrickson,et al.  Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.

[104]  Ming Ma,et al.  Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. , 2012, Biomaterials.

[105]  Wenru Zhao,et al.  Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure. , 2005, Journal of the American Chemical Society.

[106]  Tiehong Chen,et al.  Synthesis of iron-containing MCM-41 , 1995 .

[107]  B. Fadeel,et al.  Macrophage activation status determines the internalization of mesoporous silica particles of different sizes: Exploring the role of different pattern recognition receptors. , 2017, Biomaterials.

[108]  Jun Lin,et al.  Functionalized mesoporous silica materials for controlled drug delivery. , 2012, Chemical Society reviews.

[109]  Monty Liong,et al.  Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.

[110]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as nanocarriers. , 2011, Chemical communications.

[111]  Si-Han Wu,et al.  Synthesis of mesoporous silica nanoparticles. , 2013, Chemical Society reviews.

[112]  Hung-Ting Chen,et al.  Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. , 2007, Accounts of chemical research.

[113]  Jun Lin,et al.  808 nm near-infrared light controlled dual-drug release and cancer therapy in vivo by upconversion mesoporous silica nanostructures. , 2017, Journal of materials chemistry. B.

[114]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[115]  J. Gooding,et al.  Light-Induced Hydrogel Based on Tumor-Targeting Mesoporous Silica Nanoparticles as a Theranostic Platform for Sustained Cancer Treatment. , 2016, ACS applied materials & interfaces.

[116]  H. Gu,et al.  Adsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticles. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[117]  Donald D. Nolting,et al.  Molecular imaging probe development: a chemistry perspective. , 2012, American journal of nuclear medicine and molecular imaging.

[118]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[119]  Brian G. Trewyn,et al.  Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration , 2008 .

[120]  Yi Shi,et al.  Biocompatibility of Mesoporous Silica Nanoparticles? , 2016 .

[121]  Tian Xia,et al.  Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. , 2013, ACS nano.

[122]  R. Martínez‐Máñez,et al.  Self-Regulated Glucose-Sensitive Neoglycoenzyme-Capped Mesoporous Silica Nanoparticles for Insulin Delivery. , 2017, Chemistry.

[123]  C. Sanchez,et al.  Elaboration of monodisperse spherical hollow particles with ordered mesoporous silica shells via dual latex/surfactant templating: radial orientation of mesopore channels. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[124]  I. Banerjee,et al.  Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping. , 2017, Colloids and surfaces. B, Biointerfaces.

[125]  Nikola Ž. Knežević,et al.  Hydroxylated fullerene-capped, vinblastine-loaded folic acid-functionalized mesoporous silica nanoparticles for targeted anticancer therapy , 2016 .

[126]  Courtney R. Thomas,et al.  Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. , 2011, Accounts of chemical research.

[127]  H. Gu,et al.  Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging , 2014, International journal of nanomedicine.

[128]  Yanjing Li,et al.  Adsorption and catalytic activity of Porcine pancreatic lipase on rod-like SBA-15 mesoporous material , 2009 .

[129]  Yanzhong Zhang,et al.  Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging. , 2016, ACS applied materials & interfaces.

[130]  Pengcheng Zhang,et al.  Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes , 2017, Theranostics.

[131]  Christy L Haynes,et al.  Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. , 2010, Journal of the American Chemical Society.

[132]  Robert Langer,et al.  The biocompatibility of mesoporous silicates. , 2008, Biomaterials.

[133]  Y. Hung,et al.  Uniform mesoporous silica hexagon and its two-dimensional colloidal crystal. , 2009, Chemphyschem : a European journal of chemical physics and physical chemistry.

[134]  Saji George,et al.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.

[135]  Jin Xie,et al.  Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.

[136]  Hui Guo,et al.  Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. , 2009, Small.

[137]  Fan-hong Wu,et al.  Using hyaluronic acid-functionalized pH stimuli-responsive mesoporous silica nanoparticles for targeted delivery to CD44-overexpressing cancer cells , 2016, International journal of nanomedicine.

[138]  S. Rajput,et al.  Etoposide encapsulated functionalized mesoporous silica nanoparticles: Synthesis, characterization and effect of functionalization on dissolution kinetics in simulated and biorelevant media , 2018 .

[139]  Sang Cheon Lee,et al.  Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. , 2007, Angewandte Chemie.

[140]  N. Erathodiyil,et al.  Functionalization of inorganic nanoparticles for bioimaging applications. , 2011, Accounts of chemical research.

[141]  Yanli Zhao,et al.  Responsive mesoporous silica nanoparticles for sensing of hydrogen peroxide and simultaneous treatment toward heart failure. , 2017, Nanoscale.

[142]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[143]  Myung-Haing Cho,et al.  Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. , 2008, International journal of pharmaceutics.

[144]  Wenbin Lin,et al.  Mesoporous Silica Nanoparticles with Co-Condensed Gadolinium Chelates for Multimodal Imaging , 2011, Nanomaterials.

[145]  V. S. Lin,et al.  Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. , 2009, Journal of the American Chemical Society.

[146]  Isabel Díaz,et al.  Fischer–Tropsch synthesis of hydrocarbons over mesoporous Co/SBA-15 catalysts: the influence of metal loading, cobalt precursor, and promoters , 2003 .

[147]  K. Zimny,et al.  Multitechnique Investigation of Mesoporous Titanosilicate Materials Prepared from Both the Self-Assembly and the Liquid Crystal Mechanisms , 2011 .

[148]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[149]  María Vallet-Regí,et al.  Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers. , 2015, ACS nano.

[150]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[151]  Lingxin Chen,et al.  A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside. , 2013, International journal of pharmaceutics.

[152]  Caixia Huang,et al.  Fabrication of high surface area mesoporous silicon via magnesiothermic reduction for drug delivery , 2011 .

[153]  M. Toprak,et al.  Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities. , 2012, Contrast media & molecular imaging.

[154]  Wenbin Lin,et al.  Hybrid nanomaterials for biomedical applications. , 2010, Chemical Communications.

[155]  Xiaohan Liu,et al.  Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers. , 2016, Acta biomaterialia.

[156]  Chun-hua Lu,et al.  Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. , 2011, Journal of the American Chemical Society.

[157]  L. Jia,et al.  EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[158]  Chin-Tu Chen,et al.  Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.

[159]  Jinming Gao,et al.  Polymeric nanomedicine for cancer MR imaging and drug delivery. , 2009, Chemical communications.

[160]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[161]  Weihong Tan,et al.  DESIGNING A NOVEL MOLECULAR BEACON FOR SURFACE-IMMOBILIZED DNA HYBRIDIZATION STUDIES , 1999 .

[162]  María Vallet-Regí,et al.  Mesoporous silica nanoparticles for the design of smart delivery nanodevices. , 2013, Biomaterials science.

[163]  C. Batich,et al.  Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. , 2005, Journal of nanoscience and nanotechnology.

[164]  T. Asefa,et al.  Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. , 2010, ACS nano.

[165]  C. Mou,et al.  Direct Synthesis of MCM-41 Mesoporous Aluminosilicates Containing Au Nanoparticles in Aqueous Solution , 2001 .

[166]  Kristofer J. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[167]  S. Rajput,et al.  A comparative in vitro release study of raloxifene encapsulated ordered MCM-41 and MCM-48 nanoparticles: A dissolution kinetics study in simulated and biorelevant media , 2017 .

[168]  H. Kim,et al.  Indocyanine green-loaded hollow mesoporous silica nanoparticles as an activatable theranostic agent , 2017, Nanotechnology.

[169]  Glenn Walter,et al.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.

[170]  Weili Lin,et al.  Mesoporous silica nanospheres as highly efficient MRI contrast agents. , 2008, Journal of the American Chemical Society.

[171]  Taeghwan Hyeon,et al.  Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.

[172]  Hao Hong,et al.  Positron Emission Tomography Image-Guided Drug Delivery: Current Status and Future Perspectives , 2014, Molecular pharmaceutics.

[173]  A. Bhaumik,et al.  Soft templating strategies for the synthesis of mesoporous materials: inorganic, organic-inorganic hybrid and purely organic solids. , 2013, Advances in colloid and interface science.

[174]  S. Ostad,et al.  Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel , 2016, OncoTargets and therapy.

[175]  Chun-Yan Hong,et al.  Fabrication of PDEAEMA-Coated Mesoporous Silica Nanoparticles and pH-Responsive Controlled Release , 2010 .

[176]  Victor S-Y Lin,et al.  Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.

[177]  Lehui Lu,et al.  Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. , 2015, Biomaterials.

[178]  Kemin Wang,et al.  Functionalized silica nanoparticles: a platform for fluorescence imaging at the cell and small animal levels. , 2013, Accounts of chemical research.

[179]  S. M. Taghdisi,et al.  Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma. , 2017, Nanomedicine.

[180]  Y. Yamauchi,et al.  Preparation of Colloidal Mesoporous Silica Nanoparticles with Different Diameters and Their Unique Degradation Behavior in Static Aqueous Systems , 2012 .

[181]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[182]  Jun Hu,et al.  Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. , 2017, Colloids and surfaces. B, Biointerfaces.

[183]  Yoon Yeo,et al.  Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. , 2009, Molecular pharmaceutics.

[184]  W. Xia,et al.  Mesoporous Silica Nanoparticles for Cancer Therapy , 2013 .

[185]  Michael W Anderson,et al.  Simplified description of MCM-48 , 1997 .

[186]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[187]  Yaping Li,et al.  Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. , 2009, Small.

[188]  Shraboni Das,et al.  Inorganic-organic hybrid nanoparticles from n-octyl triethoxy silane. , 2002, Journal of colloid and interface science.

[189]  J. F. Stoddart,et al.  Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery. , 2015, Nanoscale.

[190]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[191]  Feng Chen,et al.  Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles , 2017, Acta Pharmacologica Sinica.

[192]  A. Maitra,et al.  Nanometer Silica Particles Encapsulating Active Compounds: A Novel Ceramic Drug Carrier , 1998 .